Brainstorm Cell Therapeutics and BiolineRX obtained funding.
The Office of the Chief Scientist has allocated NIS 12 million for biotechnology and software new projects.
Brainstorm Cell Therapeutics Ltd. (Bulletin Board:BCLI) received up to NIS 2.9 million for its 2008 work program, which includes development of a new treatment, based on adult stem cells, for the treatment of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and Parkinson's disease.
Jerusalem-based incubator BiolineRX Ltd. (TASE:BLRX) obtained funding for three projects: development of a molecule for the treatment of malignant tumors; development of a small molecule designed to kill cancer cells; and development of a protein that prevents acute renal failure.
Sde Boker incubator Iris Ventures obtained a grant to develop a software solution to improve the quality of pictures taken by cellular telephones.
Published by Globes [online], Israel business news - www.globes-online.com - on June 19, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008